Lisa A. Orband‐Miller
Lisa A. Orband‐Miller publishes mostly in Molecular Biology, Genetics and Organic Chemistry, on topics such as Estrogen and related hormone effects, Computational Drug Discovery Methods and Inflammatory mediators and NSAID effects.
- World rank
- #518,492 of 7,710,434 ranked researchers
- Rank in United States
- #180,170 of 1,627,098
- Works
- 33
- Citations
- 2.7k
- Citations per work
- 82.9
What does Lisa A. Orband‐Miller research?
Lisa A. Orband‐Miller's work is mostly in Biochemistry, Genetics and Molecular Biology (26%), Medicine (12%), Chemistry (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1648.3%
- Life Sciences1132.3%
- Health Sciences411.9%
- Medicine411.9%
- Physical Sciences27.5%
- Chemistry27.5%
- 1Molecular Biology16% of their works
- 2Genetics10% of their works
- 3Organic Chemistry8% of their works
- 4Oncology6% of their works
- 5Endocrine and Autonomic Systems6% of their works
- 6Pharmacology5% of their works
Research topics
- Estrogen and related hormone effects
- Computational Drug Discovery Methods
- Inflammatory mediators and NSAID effects
- Peroxisome Proliferator-Activated Receptors
- Psoriasis: Treatment and Pathogenesis
- Anesthesia and Neurotoxicity Research
- Neuroscience of respiration and sleep
- Adenosine and Purinergic Signaling
Which keywords describe Lisa A. Orband‐Miller's research?
The keywords of their largest research topics: Nuclear Receptors, Transcriptional Regulation, Inflammation, Estrogen, Receptor, Cancer, Cyclooxygenase-2 Inhibitors and Molecular Docking.
- Adenosine Receptors
- Respiratory Rhythm
- PPARs
- IL-17
- Anesthesia
- Molecular Docking
- Cancer
- Estrogen
- Transcriptional Regulation
- Nuclear Receptors
- Inflammation
- Receptor
- Cyclooxygenase-2 Inhibitors
- Virtual Screening
- Central Chemoreception
- Neurotoxicity
- Peroxisome Proliferator-Activated Receptors
- TH17 Cells
- Purinergic Signalling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Nuclear Receptors132 topics
- Transcriptional Regulation132 topics
- Inflammation123 topics
- Estrogen91 topic
- Receptor91 topic
- Cancer51 topic
- Cyclooxygenase-2 Inhibitors51 topic
- Molecular Docking51 topic
- Virtual Screening51 topic
- Anesthesia41 topic
- Central Chemoreception41 topic
- IL-1741 topic
- Neurotoxicity41 topic
- PPARs41 topic
- Peroxisome Proliferator-Activated Receptors41 topic
- Respiratory Rhythm41 topic
- TH17 Cells41 topic
- Adenosine Receptors31 topic
- Purinergic Signalling31 topic
Where does Lisa A. Orband‐Miller work?
Lisa A. Orband‐Miller's main affiliation in the publication record is Research Triangle Park Foundation, United States.
How many publications and citations does Lisa A. Orband‐Miller have?
OpenAlex counts 33 works and 2,736 citations for Lisa A. Orband‐Miller, an h-index of 25, ranking #518,492 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lisa A. Orband‐Miller. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.